Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $48.35 million. The enterprise value is -$15.54 million.

Market Cap	48.35M
Enterprise Value	-15.54M

Important Dates

The next estimated earnings date is Friday, May 23, 2025, after market close.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.20 million shares outstanding. The number of shares has increased by 13.80% in one year.

Current Share Class	31.20M
Shares Outstanding	31.20M
Shares Change (YoY)	+13.80%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	31.31%
Float	31.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	2.41
PB Ratio	1.88
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.35, with a Debt / Equity ratio of 0.06.

Current Ratio	9.35
Quick Ratio	9.19
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.87% and return on invested capital (ROIC) is -84.22%.

Return on Equity (ROE)	-130.87%
Return on Assets (ROA)	-39.14%
Return on Invested Capital (ROIC)	-84.22%
Return on Capital Employed (ROCE)	-79.89%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.25% in the last 52 weeks. The beta is -0.23, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	-82.25%
50-Day Moving Average	1.35
200-Day Moving Average	1.72
Relative Strength Index (RSI)	59.19
Average Volume (20 Days)	348,886

Short Selling Information

The latest short interest is 2.28 million, so 7.30% of the outstanding shares have been sold short.

Short Interest	2.28M
Short Previous Month	2.53M
Short % of Shares Out	7.30%
Short % of Float	7.34%
Short Ratio (days to cover)	5.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-49.16M
Pretax Income	-42.62M
Net Income	-45.51M
EBITDA	-48.97M
EBIT	-49.16M
Earnings Per Share (EPS)	-$1.47

Balance Sheet

The company has $65.33 million in cash and $1.43 million in debt, giving a net cash position of $63.89 million or $2.05 per share.

Cash & Cash Equivalents	65.33M
Total Debt	1.43M
Net Cash	63.89M
Net Cash Per Share	$2.05
Equity (Book Value)	25.69M
Book Value Per Share	0.82
Working Capital	59.35M

Cash Flow

Operating Cash Flow	-33.27M
Capital Expenditures	n/a
Free Cash Flow	-33.27M
FCF Per Share	-$1.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.80%
Shareholder Yield	-13.80%
Earnings Yield	-94.12%
FCF Yield	-68.81%

Analyst Forecast

The average price target for ATNM is $4.67, which is 201.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.67
Price Target Difference	201.29%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.78%

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 0.03333333:1.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	0.03333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1